Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Fuehrlein

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Integrated Pharmacy Research & Practice|July 8, 2021
Response to "Considering the Potential Benefits of Over-the-Counter Naloxone" by Evoy et al [Letter]Brian Fuehrlein
Immunotargets and Therapy|October 6, 2022
A Review of Immunotherapeutic Approaches for Substance Use Disorders: Current Status and Future ProspectsMuhammet Celik, Brian Fuehrlein
Community Mental Health Journal|January 30, 2021
Patient Volume and Dispositions in a VA Psychiatric Emergency Room During COVID-19Lorena Mitchell, Brian Fuehrlein
Journal of Integrative Neuroscience|April 30, 2025
Emerging Therapeutics in the Treatment of Substance Use Disorders: A Focus on GLP-1 Receptor Agonists, D3R Antagonists, and CRF AntagonistsKhaled Draghmeh, Brian Fuehrlein
Journal of the Neurological Sciences|February 26, 2020
Buprenorphine initiation to treat opioid use disorder in emergency roomsStephen Jaeger, Brian Fuehrlein
Exploratory Research in Clinical and Social Pharmacy|December 27, 2023
US Medicaid program: An analysis of the spending and utilization patterns for antidepressants from 2017 to 2021Mohamed Elmarasi, Brian Fuehrlein
Community Mental Health Journal|April 7, 2022
Correction to: COVID-19 Vaccine Administration and Hesitation Among Psychiatric Emergency Services PatientsLorena Mitchell, Meghan Wilkosz, Brian Fuehrlein
Community Mental Health Journal|February 12, 2022
COVID-19 Vaccine Administration and Hesitation Among Psychiatric Emergency Services PatientsLorena Mitchell, Meghan Wilkosz, Brian Fuehrlein
The American Journal on Addictions|August 3, 2024
A detox dilemma beyond benzodiazepines; clonidine's quandary in alcohol withdrawal managementMatthew Johnson, Danielle Cosentino, Brian Fuehrlein
The American Journal on Addictions|January 26, 2024
Analysis of nonfatal suicide attempts and demographic characteristics of US military veterans with opioid use disorder: A descriptive VA medical center studyMuhammet Celik, Danielle Cosentino, Brian Fuehrlein
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Integrated Pharmacy Research & Practice|July 8, 2021
Response to "Considering the Potential Benefits of Over-the-Counter Naloxone" by Evoy et al [Letter]Brian Fuehrlein
Immunotargets and Therapy|October 6, 2022
A Review of Immunotherapeutic Approaches for Substance Use Disorders: Current Status and Future ProspectsMuhammet Celik, Brian Fuehrlein
Community Mental Health Journal|January 30, 2021
Patient Volume and Dispositions in a VA Psychiatric Emergency Room During COVID-19Lorena Mitchell, Brian Fuehrlein
Journal of Integrative Neuroscience|April 30, 2025
Emerging Therapeutics in the Treatment of Substance Use Disorders: A Focus on GLP-1 Receptor Agonists, D3R Antagonists, and CRF AntagonistsKhaled Draghmeh, Brian Fuehrlein
Journal of the Neurological Sciences|February 26, 2020
Buprenorphine initiation to treat opioid use disorder in emergency roomsStephen Jaeger, Brian Fuehrlein
Exploratory Research in Clinical and Social Pharmacy|December 27, 2023
US Medicaid program: An analysis of the spending and utilization patterns for antidepressants from 2017 to 2021Mohamed Elmarasi, Brian Fuehrlein
Community Mental Health Journal|April 7, 2022
Correction to: COVID-19 Vaccine Administration and Hesitation Among Psychiatric Emergency Services PatientsLorena Mitchell, Meghan Wilkosz, Brian Fuehrlein
Community Mental Health Journal|February 12, 2022
COVID-19 Vaccine Administration and Hesitation Among Psychiatric Emergency Services PatientsLorena Mitchell, Meghan Wilkosz, Brian Fuehrlein
The American Journal on Addictions|August 3, 2024
A detox dilemma beyond benzodiazepines; clonidine's quandary in alcohol withdrawal managementMatthew Johnson, Danielle Cosentino, Brian Fuehrlein
The American Journal on Addictions|January 26, 2024
Analysis of nonfatal suicide attempts and demographic characteristics of US military veterans with opioid use disorder: A descriptive VA medical center studyMuhammet Celik, Danielle Cosentino, Brian Fuehrlein
Pageof 4